Digital Pathology market Trends, Analysis by 2035

Key Market Insights

• Presently, close to 80 players offering AI-based digital pathology services are available in the healthcare market which are located across the globe
• In order to tap into the lucrative opportunity associated with AI-based digital pathology, various investment firms have invested over USD 1.7 billion in AI-based digital pathology market space, during the period 2016-2022
• The estimated global demand for AI-based digital pathology is expected to grow at a CAGR of 9,4%, during 2022-2035
• The projected future opportunity for companies engaged in this field is expected to be well distributed across different types of neural networks, types of assay, end-users, areas of applications, target disease indications, and key geographical regions

Table of Contents

1. PREFACE

1.1.      Chapter Overview

1.2.      Market Segmentations

1.3.      Research Methodology

1.4.      Key Questions Answered

1.5.      Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1.      Chapter Overview

3.2.      Artificial Intelligence in Digital Pathology

3.3.       Workflow of AI-based Digital Pathology

3.4.       Applications of AI-based Digital Pathology Solutions

3.5.      Regulatory Requirements Focused on AI-based Digital Pathology:

3.6.      Challenges Associated with the Use of AI in Digital Pathology

3.7.      Future Perspectives

4. AI-BASED DIGITAL PATHOLOGY: MARKET LANDSCAPE

4.1.      Chapter Overview

4.2.      AI-based Digital Pathology Providers: Developers Landscape

4.3.      AI-based Digital Pathology Providers: Market Landscape

5. AI-BASED DIGITAL PATHOLOGY MARKET: KEY INSIGHTS

5.1.      Chapter Overview

6. COMPANY PROFILES

6.1.      Chapter Overview

6.2.      PathAI

6.2.1.   Company Overview

6.2.2.   Recent Developments and Future Outlook

6.3.      Paige

6.4.      Akoya Biosciences

6.5.      PROSCIA

6.6.      Visiopharm

6.7.      Roche Tissue Diagnostics

6.8.      Aiforia Technologies

6.9.      Indica Labs

6.10.    Ibex Medical Analytics

7. COMPANY COMPETITIVENESS ANALYSIS

7.1.      Chapter Overview

7.2.      Assumptions and Key Parameters

7.3.      Methodology

7.4.      Benchmarking of Portfolio Strength              

7.5.      Benchmarking of Funding Strength

7.6.      Company Competitiveness Analysis: Small Players

7.7.      Company Competitiveness Analysis: Mid-sized Players

7.8.      Company Competitiveness Analysis: Large Players

8. FUNDING AND INVESTMENTS

8.1.      Chapter Overview

8.2.      Types of Funding

8.3.      AI-based Digital Pathology: List of Funding and Investments

8.4.      Concluding Remarks

9. DEMAND ANALYSIS

9.1.      Chapter Overview

9.2.      Scope and Methodology

9.3.      Global Demand for AI-based Digital Pathology, 2022-2035

9.4.      Demand for AI-based Digital Pathology: Analysis by Geography

9.5.      Demand for AI-based Digital Pathology: Analysis by Type of End-user

9.6.      Concluding Remarks

10. MARKET SIZING AND OPPORTUNITY ANALYSIS

10.1.    Chapter Overview

10.2.    Forecast Methodology and Key Assumptions

10.3.    Global AI-based Digital Pathology Market, 2022-2035

10.4.    AI-based Digital Pathology Market: Analysis by Type of Neural Network, 2022 and 2035

10.5.    AI-based Digital Pathology Market: Analysis by Type of Assay, 2022 and 2035

10.6.    AI-based Digital Pathology Market: Analysis by Type of End-user, 2022 and 2035

10.7.    AI-based Digital Pathology Market: Analysis by Area of Application, 2022 and 2035

10.8.    AI-based Digital Pathology Market: Analysis by Target Disease Indication, 2022 and 2035

10.9.    AI-based Digital Pathology Market: Analysis by Key Geographies, 2022 and 2035

11. CONCLUDING REMARKS

12. EXECUTIVE INSIGHTS

12.1.    Chapter Overview

12.2.    aetherAI

12.3.    CTL Clinitech Lab

12.4.    Huron Digital Pathology

12.5.    Mindpeak

12.6.    Pramana

13. APPENDIX 1: TABULATED DATA

14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/ai-based-digital-pathology-market.html

Learn from experts:  do you know about these emerging industry trends?

TIL Therapies: A New Paradigm in Cancer Treatment

Viral Clearance and Viral Testing Services

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting - the preferred research partner for global firms

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com